P13-KINASE-ANTAGONISTEN

European patent · EP2015752 · In force

Register entry

Publication number
EP2015752
Application number
EP07873406
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 4, 2007
Published
Jan 21, 2009
Granted
Jun 3, 2015
Protection ends at the latest
Apr 3, 2027
Next annual fee due
Apr 30, 2027
IPC classes
A61K 31/519 (2006.01)
A61K 31/52 (2006.01)
C07D 487/04 (2006.01)
A61P 35/00 (2006.01)
Priority
US 744270 P 04.04.2006
US 744269 P 04.04.2006
PCT application
PCT/US2007/008355 04.04.2007
PCT publication
WO2008/127226 23.10.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Jun 3, 2015

    Granted

    Published in Swissreg on 03.06.2015

Parties

Holder

The Regents of the University of California

1111 Franklin Street, 12th Floor, Oakland, CA 94607, US

Inventor

KNIGHT, Zachary, A.

San Francisco, CA 94114, US

SHOKAT, Kevan, M.

San Francisco, CA 94121, US

WILLIAMS, Olusegun

Daly City, CA 90415, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.